Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/AZD1305> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- AZD1305 abstract "AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr), L-type calcium current, and inward sodium current (INa).".
- AZD1305 iupacName "2-Methyl-2-propanyl (2-{7-[2-(4-cyano-2-fluorophenoxy)ethyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl)carbamate".
- AZD1305 thumbnail AZD-1305.svg?width=300.
- AZD1305 wikiPageID "35010468".
- AZD1305 wikiPageLength "7620".
- AZD1305 wikiPageOutDegree "5".
- AZD1305 wikiPageRevisionID "670407392".
- AZD1305 wikiPageWikiLink Atrial_fibrillation.
- AZD1305 wikiPageWikiLink Atrial_flutter.
- AZD1305 wikiPageWikiLink Cardiac_arrhythmia.
- AZD1305 wikiPageWikiLink Category:Drugs_acting_on_the_cardiovascular_system.
- AZD1305 wikiPageWikiLink HERG.
- AZD1305 wikiPageWikiLinkText "AZD1305".
- AZD1305 imagefile "AZD-1305.svg".
- AZD1305 imagesize "200".
- AZD1305 iupacname "2".
- AZD1305 wikiPageUsesTemplate Template:Cascite.
- AZD1305 wikiPageUsesTemplate Template:Chembox.
- AZD1305 wikiPageUsesTemplate Template:Chembox_Hazards.
- AZD1305 wikiPageUsesTemplate Template:Chembox_Identifiers.
- AZD1305 wikiPageUsesTemplate Template:Chembox_Properties.
- AZD1305 wikiPageUsesTemplate Template:Reflist.
- AZD1305 subject Category:Drugs_acting_on_the_cardiovascular_system.
- AZD1305 hypernym Candidate.
- AZD1305 type ChemicalCompound.
- AZD1305 type ChemicalSubstance.
- AZD1305 type Drug.
- AZD1305 type Person.
- AZD1305 type Drug.
- AZD1305 type ChemicalObject.
- AZD1305 type Thing.
- AZD1305 type Q11173.
- AZD1305 comment "AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr), L-type calcium current, and inward sodium current (INa).".
- AZD1305 label "AZD1305".
- AZD1305 sameAs Q4655233.
- AZD1305 sameAs m.0j664s6.
- AZD1305 sameAs AZD1305.
- AZD1305 sameAs AZD1305.
- AZD1305 sameAs Q4655233.
- AZD1305 wasDerivedFrom AZD1305?oldid=670407392.
- AZD1305 depiction AZD-1305.svg.
- AZD1305 isPrimaryTopicOf AZD1305.